Proton beam radiation for kidney cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a precise type of radiation called stereotactic body proton therapy for people with kidney cancer who cannot have surgery or other local treatments. It aims to see if this focused radiation can control the tumor with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- Kidney cancer confirmed by a biopsy
- No evidence that the cancer has spread beyond the kidney
- Not able to have surgery or other tumor-destroying procedures
- Able to have an MRI or a CT scan with contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether targeted external-beam radiation (SBRT) can control a small number of progressing kidney cancer spots while you continue immune checkpoint inhibitor immunotherapy. It may help shrink or stop those specific “oligoprogressive” lesions and prolong benefit from your current immunotherapy.
This study tests whether a precise, high-dose radiation treatment (SABR) can safely control kidney cancer that has spread to a few spots in the body. It may be an option if your cancer is progressing during treatment and your spots can be safely targeted with radiation.
This trial studies how well people do—especially their quality of life—after SBRT radiation for primary kidney cancer that can’t be removed with surgery. It may help doctors understand which patients benefit most and what side effects to expect.
This early study tests a type of radiation delivery (“pencil beam scanning”) for certain kidney cancers in children and teens. It may help doctors better target the tumor while reducing radiation to nearby healthy tissue.
This trial uses a precise form of radiation therapy called stereotactic body radiotherapy (SBRT) that tracks the tumor during treatment to destroy kidney tumors without surgery. It may be an option if you have a kidney tumor (primary or spread from another cancer) up to 10 cm in size and you haven't had radiation to that area before.
This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.
Hear when a new Renal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.